Mz-325

N/A

Report date: 2023/11/03 11:18:53
NMEFirst In Class

Base Information

Drug NameMz-325
Drug Alias NameMz325Mz-325
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 6 inhibitorsNAD-dependent protein deacetylase sirtuin-2 inhibitors
TargetsHistone deacetylase 6NAD-dependent protein deacetylase sirtuin-2
Therapy Area/IndicationsNerve DegenerationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLeipzig University
China Registration ClassN/A

Develop Information

Active CompaniesLeipzig University
Inactive CompaniesN/A
Active IndicationsNerve DegenerationNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A